The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xue, Hao ^a   Fu, Zhenhong ^a   Chen, Yundai ^a   Xing, Youhong ^a   Liu, Jie ^a   Zhu, Hang ^a   Zhou, Xiao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SIZE; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE;

EID: 84867431302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046534     Document Type: Article

References (29)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572.
2. Zhan S, Liu M, Yao W, Hu Y, Li L, et al. (2002) Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 23: 182-185.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP, (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566.
4. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, et al. (2000) Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35: 580-586.
5. de Simone G, Pasanisi F, Contaldo F, (2010) Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 38: 13-18.
6. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, et al. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF beta superfamily. Proc Natl Acad Sci U S A 94: 11514-11519.
7. Böttner M, Suter-Crazzolara C, Schober A, Unsicker K, et al. (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297: 103-10.
8. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, et al. (1999) MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65: 2-5.
9. Li PX, Wong J, Ayed A, Ngo D, Brade AM, et al. (2000) Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275: 20127-35.
10. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, et al. (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98: 351-360.
11. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, et al. (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98: 342-350.
12. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, et al. (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50: 1054-1060.
13. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, et al. (2002) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359: 2159-2163.
14. Wollert KC, Kempf T, Peter T, Olofsson S, James S, et al. (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115: 962-971.
15. Whitworth JA, (2003) World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hyperten 21: 1983-1992.
16. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254.
17. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT, (1978) Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc 53: 271-303.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A, (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
20. Braunwald E (1997) Heart disease. 5th edition. Volume 1. Philadelphia: W.B. Saunders Company. 437 p.
21. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH, (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352.
22. Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, et al. (2007) Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 53: 284-91.
23. Kempf T, Wollert KC, (2009) Growth differentiation factor-15: a new biomarker in cardiovascular disease. Herz 34: 594-599.
24. Wollert KC, (2007) Growth-differentiation factor-15 in cardiovascular disease: from bench to bedside, and back. Basic Res Cardiol 102: 412-415.
25. Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, et al. (2010) The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction. Eur J Heart Fail 12: 1309-1316.
26. Montoro-García S, Hernández-Romero D, Jover E, García-Honrubia A, Vilchez JA, et al. (2012) Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med 23: 169-174.
27. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, (2011) Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction. Am J Cardiol 108: 955-958.
28. Wang X, Yang X, Sun K, Chen J, Song X, et al. (2009) The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci (Lond) 118 (2) (): 137-145.
29. Heger J, Schiegnitz E, von Waldthausen D, Anwar MM, Piper HM, et al. (2010) Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes. J Cell Physiol 224 (1) (): 120-6.